nivolumab
bms
['biomarker', 'nsclc', 'lcsm,(-blcsm)', 'sclc']
 2/2 it is also unfortunate that we are still pursuing one-size-fits-all trial designs in stage iii nsclc. we need to test biomarkers and #precisionmedicine concepts #asco22 #lcsm
Director, #RadBio & Thoracic #RadOnc @MGHCancerCenter |??617-726-5184 | #GoodScience #LCSM #RadBio @OncoAlert | #HeforShe #NoManels #DEI | Tweets/Views=Private